Global Oncolytic Virus Drug Treatment Supply, Demand and Key Producers, 2023-2029

Page: 111

Published Date: 06 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Oncolytic Virus Drug Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Oncolytic Virus Drug Treatment demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Oncolytic Virus Drug Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oncolytic Virus Drug Treatment that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Oncolytic Virus Drug Treatment total market, 2018-2029, (USD Million)
Global Oncolytic Virus Drug Treatment total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Oncolytic Virus Drug Treatment total market, key domestic companies and share, (USD Million)
Global Oncolytic Virus Drug Treatment revenue by player and market share 2018-2023, (USD Million)
Global Oncolytic Virus Drug Treatment total market by Type, CAGR, 2018-2029, (USD Million)
Global Oncolytic Virus Drug Treatment total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Oncolytic Virus Drug Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics and Sorrento Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oncolytic Virus Drug Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Oncolytic Virus Drug Treatment Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Oncolytic Virus Drug Treatment Market, Segmentation by Type
    Phase 1
    Phase 2
    Others

Global Oncolytic Virus Drug Treatment Market, Segmentation by Application
    Melanoma
    Prostate Cancer
    Breast Cancer
    Ovarian Cancer
    Others

Companies Profiled:
    Amgen
    Oncolytics Biotech
    Viralytics
    Transgene SA
    Oncolys BioPharma
    Targovax
    PsiOxus Therapeutics
    SillaJen Biotherapeutics
    Sorrento Therapeutics
    Lokon Pharma
    Genelux Corporation
    Vyriad
    TILT Biotherapeutics
    Cold Genesys

Key Questions Answered
1. How big is the global Oncolytic Virus Drug Treatment market?
2. What is the demand of the global Oncolytic Virus Drug Treatment market?
3. What is the year over year growth of the global Oncolytic Virus Drug Treatment market?
4. What is the total value of the global Oncolytic Virus Drug Treatment market?
5. Who are the major players in the global Oncolytic Virus Drug Treatment market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Oncolytic Virus Drug Treatment Introduction
    1.2 World Oncolytic Virus Drug Treatment Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Oncolytic Virus Drug Treatment Total Market by Region (by Headquarter Location)
        1.3.1 World Oncolytic Virus Drug Treatment Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Oncolytic Virus Drug Treatment Market Size (2018-2029)
        1.3.3 China Oncolytic Virus Drug Treatment Market Size (2018-2029)
        1.3.4 Europe Oncolytic Virus Drug Treatment Market Size (2018-2029)
        1.3.5 Japan Oncolytic Virus Drug Treatment Market Size (2018-2029)
        1.3.6 South Korea Oncolytic Virus Drug Treatment Market Size (2018-2029)
        1.3.7 ASEAN Oncolytic Virus Drug Treatment Market Size (2018-2029)
        1.3.8 India Oncolytic Virus Drug Treatment Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Oncolytic Virus Drug Treatment Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Oncolytic Virus Drug Treatment Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Oncolytic Virus Drug Treatment Consumption Value (2018-2029)
    2.2 World Oncolytic Virus Drug Treatment Consumption Value by Region
        2.2.1 World Oncolytic Virus Drug Treatment Consumption Value by Region (2018-2023)
        2.2.2 World Oncolytic Virus Drug Treatment Consumption Value Forecast by Region (2024-2029)
    2.3 United States Oncolytic Virus Drug Treatment Consumption Value (2018-2029)
    2.4 China Oncolytic Virus Drug Treatment Consumption Value (2018-2029)
    2.5 Europe Oncolytic Virus Drug Treatment Consumption Value (2018-2029)
    2.6 Japan Oncolytic Virus Drug Treatment Consumption Value (2018-2029)
    2.7 South Korea Oncolytic Virus Drug Treatment Consumption Value (2018-2029)
    2.8 ASEAN Oncolytic Virus Drug Treatment Consumption Value (2018-2029)
    2.9 India Oncolytic Virus Drug Treatment Consumption Value (2018-2029)

3 World Oncolytic Virus Drug Treatment Companies Competitive Analysis
    3.1 World Oncolytic Virus Drug Treatment Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Oncolytic Virus Drug Treatment Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Oncolytic Virus Drug Treatment in 2022
        3.2.3 Global Concentration Ratios (CR8) for Oncolytic Virus Drug Treatment in 2022
    3.3 Oncolytic Virus Drug Treatment Company Evaluation Quadrant
    3.4 Oncolytic Virus Drug Treatment Market: Overall Company Footprint Analysis
        3.4.1 Oncolytic Virus Drug Treatment Market: Region Footprint
        3.4.2 Oncolytic Virus Drug Treatment Market: Company Product Type Footprint
        3.4.3 Oncolytic Virus Drug Treatment Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Oncolytic Virus Drug Treatment Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Oncolytic Virus Drug Treatment Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Oncolytic Virus Drug Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Oncolytic Virus Drug Treatment Consumption Value Comparison
        4.2.1 United States VS China: Oncolytic Virus Drug Treatment Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Oncolytic Virus Drug Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Oncolytic Virus Drug Treatment Companies and Market Share, 2018-2023
        4.3.1 United States Based Oncolytic Virus Drug Treatment Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Oncolytic Virus Drug Treatment Revenue, (2018-2023)
    4.4 China Based Companies Oncolytic Virus Drug Treatment Revenue and Market Share, 2018-2023
        4.4.1 China Based Oncolytic Virus Drug Treatment Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Oncolytic Virus Drug Treatment Revenue, (2018-2023)
    4.5 Rest of World Based Oncolytic Virus Drug Treatment Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Oncolytic Virus Drug Treatment Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Oncolytic Virus Drug Treatment Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Oncolytic Virus Drug Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Phase 1
        5.2.2 Phase 2
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Oncolytic Virus Drug Treatment Market Size by Type (2018-2023)
        5.3.2 World Oncolytic Virus Drug Treatment Market Size by Type (2024-2029)
        5.3.3 World Oncolytic Virus Drug Treatment Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Oncolytic Virus Drug Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Melanoma
        6.2.2 Prostate Cancer
        6.2.3 Breast Cancer
        6.2.4 Ovarian Cancer
        6.2.5 Ovarian Cancer
    6.3 Market Segment by Application
        6.3.1 World Oncolytic Virus Drug Treatment Market Size by Application (2018-2023)
        6.3.2 World Oncolytic Virus Drug Treatment Market Size by Application (2024-2029)
        6.3.3 World Oncolytic Virus Drug Treatment Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Amgen
        7.1.1 Amgen Details
        7.1.2 Amgen Major Business
        7.1.3 Amgen Oncolytic Virus Drug Treatment Product and Services
        7.1.4 Amgen Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Amgen Recent Developments/Updates
        7.1.6 Amgen Competitive Strengths & Weaknesses
    7.2 Oncolytics Biotech
        7.2.1 Oncolytics Biotech Details
        7.2.2 Oncolytics Biotech Major Business
        7.2.3 Oncolytics Biotech Oncolytic Virus Drug Treatment Product and Services
        7.2.4 Oncolytics Biotech Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Oncolytics Biotech Recent Developments/Updates
        7.2.6 Oncolytics Biotech Competitive Strengths & Weaknesses
    7.3 Viralytics
        7.3.1 Viralytics Details
        7.3.2 Viralytics Major Business
        7.3.3 Viralytics Oncolytic Virus Drug Treatment Product and Services
        7.3.4 Viralytics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Viralytics Recent Developments/Updates
        7.3.6 Viralytics Competitive Strengths & Weaknesses
    7.4 Transgene SA
        7.4.1 Transgene SA Details
        7.4.2 Transgene SA Major Business
        7.4.3 Transgene SA Oncolytic Virus Drug Treatment Product and Services
        7.4.4 Transgene SA Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Transgene SA Recent Developments/Updates
        7.4.6 Transgene SA Competitive Strengths & Weaknesses
    7.5 Oncolys BioPharma
        7.5.1 Oncolys BioPharma Details
        7.5.2 Oncolys BioPharma Major Business
        7.5.3 Oncolys BioPharma Oncolytic Virus Drug Treatment Product and Services
        7.5.4 Oncolys BioPharma Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Oncolys BioPharma Recent Developments/Updates
        7.5.6 Oncolys BioPharma Competitive Strengths & Weaknesses
    7.6 Targovax
        7.6.1 Targovax Details
        7.6.2 Targovax Major Business
        7.6.3 Targovax Oncolytic Virus Drug Treatment Product and Services
        7.6.4 Targovax Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Targovax Recent Developments/Updates
        7.6.6 Targovax Competitive Strengths & Weaknesses
    7.7 PsiOxus Therapeutics
        7.7.1 PsiOxus Therapeutics Details
        7.7.2 PsiOxus Therapeutics Major Business
        7.7.3 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Product and Services
        7.7.4 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 PsiOxus Therapeutics Recent Developments/Updates
        7.7.6 PsiOxus Therapeutics Competitive Strengths & Weaknesses
    7.8 SillaJen Biotherapeutics
        7.8.1 SillaJen Biotherapeutics Details
        7.8.2 SillaJen Biotherapeutics Major Business
        7.8.3 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Product and Services
        7.8.4 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 SillaJen Biotherapeutics Recent Developments/Updates
        7.8.6 SillaJen Biotherapeutics Competitive Strengths & Weaknesses
    7.9 Sorrento Therapeutics
        7.9.1 Sorrento Therapeutics Details
        7.9.2 Sorrento Therapeutics Major Business
        7.9.3 Sorrento Therapeutics Oncolytic Virus Drug Treatment Product and Services
        7.9.4 Sorrento Therapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Sorrento Therapeutics Recent Developments/Updates
        7.9.6 Sorrento Therapeutics Competitive Strengths & Weaknesses
    7.10 Lokon Pharma
        7.10.1 Lokon Pharma Details
        7.10.2 Lokon Pharma Major Business
        7.10.3 Lokon Pharma Oncolytic Virus Drug Treatment Product and Services
        7.10.4 Lokon Pharma Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Lokon Pharma Recent Developments/Updates
        7.10.6 Lokon Pharma Competitive Strengths & Weaknesses
    7.11 Genelux Corporation
        7.11.1 Genelux Corporation Details
        7.11.2 Genelux Corporation Major Business
        7.11.3 Genelux Corporation Oncolytic Virus Drug Treatment Product and Services
        7.11.4 Genelux Corporation Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Genelux Corporation Recent Developments/Updates
        7.11.6 Genelux Corporation Competitive Strengths & Weaknesses
    7.12 Vyriad
        7.12.1 Vyriad Details
        7.12.2 Vyriad Major Business
        7.12.3 Vyriad Oncolytic Virus Drug Treatment Product and Services
        7.12.4 Vyriad Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Vyriad Recent Developments/Updates
        7.12.6 Vyriad Competitive Strengths & Weaknesses
    7.13 TILT Biotherapeutics
        7.13.1 TILT Biotherapeutics Details
        7.13.2 TILT Biotherapeutics Major Business
        7.13.3 TILT Biotherapeutics Oncolytic Virus Drug Treatment Product and Services
        7.13.4 TILT Biotherapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 TILT Biotherapeutics Recent Developments/Updates
        7.13.6 TILT Biotherapeutics Competitive Strengths & Weaknesses
    7.14 Cold Genesys
        7.14.1 Cold Genesys Details
        7.14.2 Cold Genesys Major Business
        7.14.3 Cold Genesys Oncolytic Virus Drug Treatment Product and Services
        7.14.4 Cold Genesys Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Cold Genesys Recent Developments/Updates
        7.14.6 Cold Genesys Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Oncolytic Virus Drug Treatment Industry Chain
    8.2 Oncolytic Virus Drug Treatment Upstream Analysis
    8.3 Oncolytic Virus Drug Treatment Midstream Analysis
    8.4 Oncolytic Virus Drug Treatment Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Oncolytic Virus Drug Treatment Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Oncolytic Virus Drug Treatment Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Oncolytic Virus Drug Treatment Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Oncolytic Virus Drug Treatment Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Oncolytic Virus Drug Treatment Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Oncolytic Virus Drug Treatment Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Oncolytic Virus Drug Treatment Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Oncolytic Virus Drug Treatment Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Oncolytic Virus Drug Treatment Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Oncolytic Virus Drug Treatment Players in 2022
    Table 12. World Oncolytic Virus Drug Treatment Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Oncolytic Virus Drug Treatment Company Evaluation Quadrant
    Table 14. Head Office of Key Oncolytic Virus Drug Treatment Player
    Table 15. Oncolytic Virus Drug Treatment Market: Company Product Type Footprint
    Table 16. Oncolytic Virus Drug Treatment Market: Company Product Application Footprint
    Table 17. Oncolytic Virus Drug Treatment Mergers & Acquisitions Activity
    Table 18. United States VS China Oncolytic Virus Drug Treatment Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Oncolytic Virus Drug Treatment Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Oncolytic Virus Drug Treatment Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Oncolytic Virus Drug Treatment Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Oncolytic Virus Drug Treatment Revenue Market Share (2018-2023)
    Table 23. China Based Oncolytic Virus Drug Treatment Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Oncolytic Virus Drug Treatment Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Oncolytic Virus Drug Treatment Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Oncolytic Virus Drug Treatment Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Oncolytic Virus Drug Treatment Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Oncolytic Virus Drug Treatment Revenue Market Share (2018-2023)
    Table 29. World Oncolytic Virus Drug Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Oncolytic Virus Drug Treatment Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Oncolytic Virus Drug Treatment Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Oncolytic Virus Drug Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Oncolytic Virus Drug Treatment Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Oncolytic Virus Drug Treatment Market Size by Application (2024-2029) & (USD Million)
    Table 35. Amgen Basic Information, Area Served and Competitors
    Table 36. Amgen Major Business
    Table 37. Amgen Oncolytic Virus Drug Treatment Product and Services
    Table 38. Amgen Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Amgen Recent Developments/Updates
    Table 40. Amgen Competitive Strengths & Weaknesses
    Table 41. Oncolytics Biotech Basic Information, Area Served and Competitors
    Table 42. Oncolytics Biotech Major Business
    Table 43. Oncolytics Biotech Oncolytic Virus Drug Treatment Product and Services
    Table 44. Oncolytics Biotech Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Oncolytics Biotech Recent Developments/Updates
    Table 46. Oncolytics Biotech Competitive Strengths & Weaknesses
    Table 47. Viralytics Basic Information, Area Served and Competitors
    Table 48. Viralytics Major Business
    Table 49. Viralytics Oncolytic Virus Drug Treatment Product and Services
    Table 50. Viralytics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Viralytics Recent Developments/Updates
    Table 52. Viralytics Competitive Strengths & Weaknesses
    Table 53. Transgene SA Basic Information, Area Served and Competitors
    Table 54. Transgene SA Major Business
    Table 55. Transgene SA Oncolytic Virus Drug Treatment Product and Services
    Table 56. Transgene SA Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Transgene SA Recent Developments/Updates
    Table 58. Transgene SA Competitive Strengths & Weaknesses
    Table 59. Oncolys BioPharma Basic Information, Area Served and Competitors
    Table 60. Oncolys BioPharma Major Business
    Table 61. Oncolys BioPharma Oncolytic Virus Drug Treatment Product and Services
    Table 62. Oncolys BioPharma Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Oncolys BioPharma Recent Developments/Updates
    Table 64. Oncolys BioPharma Competitive Strengths & Weaknesses
    Table 65. Targovax Basic Information, Area Served and Competitors
    Table 66. Targovax Major Business
    Table 67. Targovax Oncolytic Virus Drug Treatment Product and Services
    Table 68. Targovax Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Targovax Recent Developments/Updates
    Table 70. Targovax Competitive Strengths & Weaknesses
    Table 71. PsiOxus Therapeutics Basic Information, Area Served and Competitors
    Table 72. PsiOxus Therapeutics Major Business
    Table 73. PsiOxus Therapeutics Oncolytic Virus Drug Treatment Product and Services
    Table 74. PsiOxus Therapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. PsiOxus Therapeutics Recent Developments/Updates
    Table 76. PsiOxus Therapeutics Competitive Strengths & Weaknesses
    Table 77. SillaJen Biotherapeutics Basic Information, Area Served and Competitors
    Table 78. SillaJen Biotherapeutics Major Business
    Table 79. SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Product and Services
    Table 80. SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. SillaJen Biotherapeutics Recent Developments/Updates
    Table 82. SillaJen Biotherapeutics Competitive Strengths & Weaknesses
    Table 83. Sorrento Therapeutics Basic Information, Area Served and Competitors
    Table 84. Sorrento Therapeutics Major Business
    Table 85. Sorrento Therapeutics Oncolytic Virus Drug Treatment Product and Services
    Table 86. Sorrento Therapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Sorrento Therapeutics Recent Developments/Updates
    Table 88. Sorrento Therapeutics Competitive Strengths & Weaknesses
    Table 89. Lokon Pharma Basic Information, Area Served and Competitors
    Table 90. Lokon Pharma Major Business
    Table 91. Lokon Pharma Oncolytic Virus Drug Treatment Product and Services
    Table 92. Lokon Pharma Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Lokon Pharma Recent Developments/Updates
    Table 94. Lokon Pharma Competitive Strengths & Weaknesses
    Table 95. Genelux Corporation Basic Information, Area Served and Competitors
    Table 96. Genelux Corporation Major Business
    Table 97. Genelux Corporation Oncolytic Virus Drug Treatment Product and Services
    Table 98. Genelux Corporation Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Genelux Corporation Recent Developments/Updates
    Table 100. Genelux Corporation Competitive Strengths & Weaknesses
    Table 101. Vyriad Basic Information, Area Served and Competitors
    Table 102. Vyriad Major Business
    Table 103. Vyriad Oncolytic Virus Drug Treatment Product and Services
    Table 104. Vyriad Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Vyriad Recent Developments/Updates
    Table 106. Vyriad Competitive Strengths & Weaknesses
    Table 107. TILT Biotherapeutics Basic Information, Area Served and Competitors
    Table 108. TILT Biotherapeutics Major Business
    Table 109. TILT Biotherapeutics Oncolytic Virus Drug Treatment Product and Services
    Table 110. TILT Biotherapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. TILT Biotherapeutics Recent Developments/Updates
    Table 112. Cold Genesys Basic Information, Area Served and Competitors
    Table 113. Cold Genesys Major Business
    Table 114. Cold Genesys Oncolytic Virus Drug Treatment Product and Services
    Table 115. Cold Genesys Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 116. Global Key Players of Oncolytic Virus Drug Treatment Upstream (Raw Materials)
    Table 117. Oncolytic Virus Drug Treatment Typical Customers
List of Figure
    Figure 1. Oncolytic Virus Drug Treatment Picture
    Figure 2. World Oncolytic Virus Drug Treatment Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Oncolytic Virus Drug Treatment Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Oncolytic Virus Drug Treatment Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Oncolytic Virus Drug Treatment Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Oncolytic Virus Drug Treatment Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Oncolytic Virus Drug Treatment Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Oncolytic Virus Drug Treatment Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Oncolytic Virus Drug Treatment Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Oncolytic Virus Drug Treatment Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Oncolytic Virus Drug Treatment Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Oncolytic Virus Drug Treatment Revenue (2018-2029) & (USD Million)
    Figure 13. Oncolytic Virus Drug Treatment Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Oncolytic Virus Drug Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Oncolytic Virus Drug Treatment Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Oncolytic Virus Drug Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Oncolytic Virus Drug Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Oncolytic Virus Drug Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Oncolytic Virus Drug Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Oncolytic Virus Drug Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Oncolytic Virus Drug Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Oncolytic Virus Drug Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Oncolytic Virus Drug Treatment by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Oncolytic Virus Drug Treatment Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Oncolytic Virus Drug Treatment Markets in 2022
    Figure 27. United States VS China: Oncolytic Virus Drug Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Oncolytic Virus Drug Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Oncolytic Virus Drug Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Oncolytic Virus Drug Treatment Market Size Market Share by Type in 2022
    Figure 31. Phase 1
    Figure 32. Phase 2
    Figure 33. Others
    Figure 34. World Oncolytic Virus Drug Treatment Market Size Market Share by Type (2018-2029)
    Figure 35. World Oncolytic Virus Drug Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Oncolytic Virus Drug Treatment Market Size Market Share by Application in 2022
    Figure 37. Melanoma
    Figure 38. Prostate Cancer
    Figure 39. Breast Cancer
    Figure 40. Ovarian Cancer
    Figure 41. Others
    Figure 42. Oncolytic Virus Drug Treatment Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Oncolytic Virus Drug Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Oncolytic Virus Drug Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 27 Feb 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Oncolytic Virus Drug Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Oncolytic Virus Drug Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Oncolytic Virus Drug Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 06 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Oncolytic Virus Drug Treatment market size was valued at USD 6 million in 2023 and is forecast to a readjusted size of USD 28 million by 2030 with a CAGR of 23.8% during review period.

Global Oncolytic Virus Drug Treatment Supply, Demand and Key Producers, 2024-2030

Global Oncolytic Virus Drug Treatment Supply, Demand and Key Producers, 2024-2030

date 27 Feb 2024

date Pharma & Healthcare

The global Oncolytic Virus Drug Treatment market size is expected to reach $ 28 million by 2030, rising at a market growth of 23.8% CAGR during the forecast period (2024-2030).

Product Tags

Oncolytic Virus Drug Treatment

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>